Your browser doesn't support javascript.
loading
Dapagliflozin and Diuretic Use in Patients With Heart Failure and Reduced Ejection Fraction in DAPA-HF.
Jackson, Alice M; Dewan, Pooja; Anand, Inder S; Belohlávek, Jan; Bengtsson, Olof; de Boer, Rudolf A; Böhm, Michael; Boulton, David W; Chopra, Vijay K; DeMets, David L; Docherty, Kieran F; Dukát, Andrej; Greasley, Peter J; Howlett, Jonathan G; Inzucchi, Silvio E; Katova, Tzvetana; Køber, Lars; Kosiborod, Mikhail N; Langkilde, Anna Maria; Lindholm, Daniel; Ljungman, Charlotta E A; Martinez, Felipe A; O'Meara, Eileen; Sabatine, Marc S; Sjöstrand, Mikaela; Solomon, Scott D; Tereshchenko, Sergey; Verma, Subodh; Jhund, Pardeep S; McMurray, John J V.
Affiliation
  • Jackson AM; BHF Cardiovascular Research Centre, University of Glasgow, UK (A.M.J., P.D., K.F.D., P.S.J., J.J.V.M.).
  • Dewan P; BHF Cardiovascular Research Centre, University of Glasgow, UK (A.M.J., P.D., K.F.D., P.S.J., J.J.V.M.).
  • Anand IS; Department of Cardiology, University of Minnesota, Minneapolis (I.S.A.).
  • Belohlávek J; 2nd Department of Internal Medicine, Cardiovascular Medicine, General Teaching Hospital and 1st Faculty of Medicine, Charles University, Prague, Czech Republic (J.B.).
  • Bengtsson O; Late Stage Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D (O.B., A.M.L., D.L., M.S.), AstraZeneca, Gothenburg, Sweden.
  • de Boer RA; Department of Cardiology, University Medical Center and University of Groningen, The Netherlands (R.A.d.B.).
  • Böhm M; Department of Medicine, Saarland University Hospital, Homburg-Saar, Germany (M.B.).
  • Boulton DW; Quantitative Clinical Pharmacology, IMED Biotech Unit, Astra-Zeneca, Gaithersburg, MD (D.W.B.).
  • Chopra VK; Department of Cardiology, Medanta, Gurgaon, India (V.K.C.).
  • DeMets DL; Department of Biostatistics and Medical Informatics, University of Wisconsin, Madison (D.L.D.).
  • Docherty KF; BHF Cardiovascular Research Centre, University of Glasgow, UK (A.M.J., P.D., K.F.D., P.S.J., J.J.V.M.).
  • Dukát A; 5th Department of Internal Medicine, Comenius University in Bratislava, Slovakia (A.D.).
  • Greasley PJ; Cardiovascular, Renal and Metabolism Translational Medicines Unit, Early Clinical Development, IMED Biotech Unit (P.J.G.), AstraZeneca, Gothenburg, Sweden.
  • Howlett JG; Cumming School of Medicine and Libin Cardiovascular Institute, University of Calgary, AB, Canada (J.G.W.).
  • Inzucchi SE; Section of Endocrinology, Yale University School of Medicine, New Haven, CT (S.E.I.).
  • Katova T; Clinic of Cardiology, National Cardiology Hospital, Sofia, Bulgaria (T.K.).
  • Køber L; Rigshospitalet Copenhagen University Hospital, Denmark (L.K.).
  • Kosiborod MN; Saint Luke's Mid America Heart Institute, University of Missouri, Kansas City (M.N.K.).
  • Langkilde AM; Late Stage Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D (O.B., A.M.L., D.L., M.S.), AstraZeneca, Gothenburg, Sweden.
  • Lindholm D; Late Stage Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D (O.B., A.M.L., D.L., M.S.), AstraZeneca, Gothenburg, Sweden.
  • Ljungman CEA; Department of Molecular and Clinical Medicine and Cardiology, Sahlgrenska Academy, Gothenburg, Sweden (C.E.A.L.).
  • Martinez FA; National University of Cordoba, Argentina (F.A.M.).
  • O'Meara E; Department of Cardiology, Montreal Heart Institute, QC, Canada (E.O.).
  • Sabatine MS; Division of Cardiovascular Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA (M.S.S., S.D.S.).
  • Sjöstrand M; Late Stage Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D (O.B., A.M.L., D.L., M.S.), AstraZeneca, Gothenburg, Sweden.
  • Solomon SD; Division of Cardiovascular Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA (M.S.S., S.D.S.).
  • Tereshchenko S; Department of Myocardial Disease and Heart Failure, National Medical Research Center of Cardiology, Moscow, Russia (S.T.).
  • Verma S; Division of Cardiac Surgery, St. Michael's Hospital, University of Toronto, ON, Canada (S.V.).
  • Jhund PS; BHF Cardiovascular Research Centre, University of Glasgow, UK (A.M.J., P.D., K.F.D., P.S.J., J.J.V.M.).
  • McMurray JJV; BHF Cardiovascular Research Centre, University of Glasgow, UK (A.M.J., P.D., K.F.D., P.S.J., J.J.V.M.).
Circulation ; 142(11): 1040-1054, 2020 09 15.
Article in En | MEDLINE | ID: mdl-32673497
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Stroke Volume / Benzhydryl Compounds / Diuretics / Glucosides / Heart Failure Type of study: Clinical_trials Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Circulation Year: 2020 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Stroke Volume / Benzhydryl Compounds / Diuretics / Glucosides / Heart Failure Type of study: Clinical_trials Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Circulation Year: 2020 Document type: Article